tradingkey.logo
tradingkey.logo

CareDx Inc

CDNA
19.450USD
+0.260+1.35%
終値 12/19, 16:00ET15分遅れの株価
999.87M時価総額
14.42直近12ヶ月PER

CareDx Inc

19.450
+0.260+1.35%

詳細情報 CareDx Inc 企業名

CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.

CareDx Incの企業情報

企業コードCDNA
会社名CareDx Inc
上場日Jul 17, 2014
最高経営責任者「CEO」Hanna (John W)
従業員数644
証券種類Ordinary Share
決算期末Jul 17
本社所在地8000 Marina Blvd
都市BRISBANE
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号94005
電話番号14152872300
ウェブサイトhttps://www.caredx.com/
企業コードCDNA
上場日Jul 17, 2014
最高経営責任者「CEO」Hanna (John W)

CareDx Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Peter Maag, Ph.D.
Dr. Peter Maag, Ph.D.
Independent Director
Independent Director
298.28K
-3.24%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
145.40K
+1.22%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
144.69K
+9.13%
Ms. Jessica Meng
Ms. Jessica Meng
Chief Commercial Officer
Chief Commercial Officer
109.63K
-4.11%
Mr. William A. (Bill) Hagstrom
Mr. William A. (Bill) Hagstrom
Independent Director
Independent Director
43.41K
--
Mr. Nathan Smith
Mr. Nathan Smith
Chief Financial Officer
Chief Financial Officer
42.00K
--
Ms. Christine M. Cournoyer
Ms. Christine M. Cournoyer
Independent Director
Independent Director
38.58K
+45.71%
Mr. Suresh Gunasekaran
Mr. Suresh Gunasekaran
Director
Director
27.45K
--
Mr. Jeffrey Adam Novack
Mr. Jeffrey Adam Novack
General Counsel, Secretary
General Counsel, Secretary
10.20K
-41.70%
Ms. Caroline Corner
Ms. Caroline Corner
Investor Relations
Investor Relations
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Peter Maag, Ph.D.
Dr. Peter Maag, Ph.D.
Independent Director
Independent Director
298.28K
-3.24%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
145.40K
+1.22%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
144.69K
+9.13%
Ms. Jessica Meng
Ms. Jessica Meng
Chief Commercial Officer
Chief Commercial Officer
109.63K
-4.11%
Mr. William A. (Bill) Hagstrom
Mr. William A. (Bill) Hagstrom
Independent Director
Independent Director
43.41K
--
Mr. Nathan Smith
Mr. Nathan Smith
Chief Financial Officer
Chief Financial Officer
42.00K
--

収益内訳

FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Testing Service revenue
62.03M
0.00%
Digital and other revenue
12.81M
0.00%
Product revenue
11.83M
0.00%
地域別USD
会社名
収益
比率
United States
81.64M
0.00%
Rest of the world
5.04M
0.00%
事業別
地域別
事業別USD
会社名
収益
比率
Testing Service revenue
62.03M
0.00%
Digital and other revenue
12.81M
0.00%
Product revenue
11.83M
0.00%

株主

更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
8.01%
The Vanguard Group, Inc.
7.27%
Baron Capital Management, Inc.
6.13%
State Street Investment Management (US)
4.99%
Ophir Asset Management Pty Ltd
4.27%
他の
69.32%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
8.01%
The Vanguard Group, Inc.
7.27%
Baron Capital Management, Inc.
6.13%
State Street Investment Management (US)
4.99%
Ophir Asset Management Pty Ltd
4.27%
他の
69.32%
種類
株主統計
比率
Investment Advisor/Hedge Fund
41.33%
Investment Advisor
35.53%
Hedge Fund
21.21%
Individual Investor
3.80%
Research Firm
3.27%
Pension Fund
0.59%
Bank and Trust
0.39%
Insurance Company
0.04%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
443
52.64M
115.22%
+43.46K
2025Q3
457
52.61M
115.96%
-1.80M
2025Q2
454
53.72M
112.39%
-1.85M
2025Q1
443
55.89M
106.19%
-3.01M
2024Q4
439
52.97M
108.30%
+1.05M
2024Q3
434
51.58M
120.50%
-825.62K
2024Q2
407
52.51M
127.45%
-1.22M
2024Q1
435
53.86M
132.45%
-14.73M
2023Q4
448
52.78M
128.80%
-2.04M
2023Q3
476
54.42M
142.26%
-1.69M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
4.07M
7.64%
-142.46K
-3.39%
Jun 30, 2025
The Vanguard Group, Inc.
4.90M
9.21%
+76.50K
+1.59%
Jun 30, 2025
Baron Capital Management, Inc.
2.44M
4.58%
+245.65K
+11.22%
Jun 30, 2025
State Street Investment Management (US)
2.18M
4.1%
-304.45K
-12.25%
Jun 30, 2025
Ophir Asset Management Pty Ltd
1.89M
3.56%
+274.63K
+16.97%
Jun 30, 2025
ARK Investment Management LLC
2.10M
3.95%
-247.22K
-10.53%
Jun 30, 2025
Amova Asset Management Co., Ltd.
1.24M
2.32%
-139.83K
-10.16%
Jun 30, 2025
Gagnon Securities LLC
2.13M
4.01%
+585.21K
+37.78%
Jul 17, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
ARK Genomic Revolution ETF
2.89%
ROBO Global Healthcare Technology & Innovation ETF
1.93%
Global X Genomics & Biotechnology ETF
0.87%
Franklin Genomic Advancements ETF
0.72%
State Street SPDR S&P Biotech ETF
0.34%
Direxion Daily S&P Biotech Bull 3X Shares
0.21%
iShares Micro-Cap ETF
0.16%
Fidelity Enhanced Small Cap ETF
0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.11%
Principal U.S. Small-Cap ETF
0.1%
詳細を見る
ARK Genomic Revolution ETF
比率2.89%
ROBO Global Healthcare Technology & Innovation ETF
比率1.93%
Global X Genomics & Biotechnology ETF
比率0.87%
Franklin Genomic Advancements ETF
比率0.72%
State Street SPDR S&P Biotech ETF
比率0.34%
Direxion Daily S&P Biotech Bull 3X Shares
比率0.21%
iShares Micro-Cap ETF
比率0.16%
Fidelity Enhanced Small Cap ETF
比率0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.11%
Principal U.S. Small-Cap ETF
比率0.1%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

CareDx Incの上位5名の株主は誰ですか?

CareDx Incの上位5名の株主は以下のとおりです。
BlackRock Institutional Trust Company, N.A.は4.07M株を保有しており、これは全体の7.64%に相当します。
The Vanguard Group, Inc.は4.90M株を保有しており、これは全体の9.21%に相当します。
Baron Capital Management, Inc.は2.44M株を保有しており、これは全体の4.58%に相当します。
State Street Investment Management (US)は2.18M株を保有しており、これは全体の4.10%に相当します。
Ophir Asset Management Pty Ltdは1.89M株を保有しており、これは全体の3.56%に相当します。

CareDx Incの株主タイプ上位3種は何ですか?

CareDx Incの株主タイプ上位3種は、
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Baron Capital Management, Inc.

CareDx Inc(CDNA)の株式を保有している機関の数はいくつですか?

2025Q4時点で、CareDx Incの株式を保有している機関は443社あり、保有株式の総市場価値は約52.64Mで、全体の115.22%を占めています。2025Q3と比較して、機関の持ち株は-0.74%増加しています。

CareDx Incの最大の収益源は何ですか?

FY2025Q2において、Testing Service revenue部門がCareDx Incにとって最大の収益を生み出しており、その金額は62.03Mで、全収益の--%を占めています。
KeyAI